Member Profiles

Allison E. Aiello, PhD, MS

James S. Jackson Healthy Longevity Professor of Epidemiology, Department of Epidemiology and the Robert N. Butler Columbia Aging Center, Mailman School of Public Health, Columbia University, New York, New York

Dr. Aiello is a nationally recognized expert in epidemiology, preparedness, and disease prevention in community settings. She also previously held the position of professor of epidemiology and was a Carolina Population Center Fellow at the University of North Carolina at Chapel Hill's Gillings School of Global Public Health. Dr. Aiello leads field studies with social, immunological, and genomic data collection in large-scale research studies. Her research program examines how socioeconomic status influences a range of health outcomes and the prevention of respiratory infections in community settings.

Joshua Adam Barocas, MD

Associate Professor of Medicine, University of Colorado School of Medicine, Divisions of General Internal Medicine and Infectious Diseases, Aurora, Colorado

Dr. Barocas is a recognized leader in infectious diseases medicine with strong community connections serving some of the most underserved and marginalized populations. He is currently the principal investigator on a highly prestigious DP2 grant award from the National Institute on Drug Abuse that aims to modernize local data and surveillance to improve our understanding of stigmatized and difficult-to-diagnose diseases. Dr. Barocas also has noteworthy contributions to academia both through his teaching and mentorship and through published peer-reviewed works.

Virginia A. Caine, MD

Director and Chief Medical Officer, Marion County Public Health Department, Indianapolis, Indiana

Dr. Caine is nationally regarded for her work in public health and infectious diseases, notably in HIV/AIDS prevention and treatment. In addition to her positions at the Marion County Public Health Department, Dr. Caine is a Bicentennial Associate Professor of Medicine in the Indiana University School of Medicine's Infectious Diseases Division. She is a member of the COVID-19 Task Force of the National Medical Association, an organization where she is a former Chairman of the Board of Trustees and current Chair of the Infectious Diseases Section.

Angela M. Caliendo, MD, PhD

Warren Alpert Foundation Professor and Executive Vice Chair of Medicine, Warren Alpert Medical School, Brown University, Providence, Rhode Island

In addition to her role as President of Brown Physicians, Inc., Dr. Caliendo also serves as the Executive Vice Chair of Medicine and Vice President of Brown Medicine, Inc. Her research has focused on the development of molecular diagnostic tests for the detection and quantification of infectious diseases and assessment of their clinical utility; molecular testing in transplantation; and standardization of viral load testing. Dr. Caliendo's laboratory has participated in numerous clinical studies assessing newer diagnostics for infectious diseases.

Tri D. Do, MD, MPH

Assistant Professor, Department of Medicine, Division of Prevention Science, University of California San Francisco (UCSF), San Francisco, California

Dr. Do has extensive scientific and clinical experience in STIs, HIV, hepatitis, and health disparities. At UCSF, his research focuses on the social epidemiology of health disparities in vulnerable populations including LGBTQ populations in the United States and globally. Dr. Do has provided global medical support and training for HIV clinic scale-up for CDC. As a former head of clinical science for a molecular diagnostics company, he has been involved in the development of many infectious disease assays in current use. Dr. Do is also Chief Medical Officer of Community Health Center Network, serving safety patients in Alameda County where he served as Deputy COVID-19 Vaccine Lead for the county and developed its point of care testing algorithm.

Anthony Richard Flores, MD, MPH, PhD

Director of Pediatric Infectious Diseases, Professor, Department of Pediatrics, Vanderbilt Institute for Infection, Immunology and Inflammation, Nashville, TN

Christine Gabriele Hahn, MD

State Epidemiologist and Medical Director, Division of Public Health, Idaho Department of Health and Welfare, Boise, Idaho

After a fellowship in infectious diseases at Duke University, Dr. Hahn trained as a CDC Epidemic Intelligence Service Officer before serving in her current role, where she is actively engaged in infectious disease public health practice at the state level and also at the national and international levels, focusing on influenza surveillance, immunization policy, tuberculosis prevention and treatment, and the epidemiology of vaccine-preventable diseases. Dr. Hahn has provided surveillance evaluations and training courses in multiple countries, including Ethiopia, Ukraine, Moldova, Bhutan, Jamaica, and Croatia. She contributed to the national and local response to COVID-19 pandemic and has published in both CDC journals and the peer-reviewed literature on a range of infectious disease topics.

Anil T. Mangla, PhD, MPH, FRIPH

Director of Disease Surveillance and Control, Southern Nevada Health District

Dr. Anil T. Mangla is a distinguished epidemiologist with extensive experience in public health research, academia, and infectious disease control. He holds advanced degrees in epidemiology and has contributed significantly to understanding and mitigating the spread of various infectious diseases. Dr. Mangla's work is characterized by his innovative approach to disease surveillance, particularly in urban and community settings. He has collaborated with several health departments and academic institutions, providing valuable insights of epidemiology in many areas such as substance abuse, informatics, zoonotic diseases, healthcare-acquired infections, HIV/AIDS, and tuberculosis. As a former state epidemiologist for Washington, D.C., and a faculty member at the University of Nevada Las Vegas, School of Public Health, Dr. Mangla is highly regarded for his commitment to improving public health through evidence-based practices and his dedication to training the next generation of epidemiologists.

Lauren Ancel Meyers, PhD (Chair)

Cooley Centennial Professor, Departments of Integrative Biology and Statistics & Data Sciences, The University of Texas, Austin, Texas

At The University of Texas (UT) at Austin, Dr. Meyers was founding Chair of the Department of Statistics and Data Sciences and is founding Director of the UT COVID-19 Modeling Consortium, a national center for pandemic modeling. She also serves as external faculty at the Santa Fe Institute (New Mexico). For more than 20 years, Dr. Meyers has pioneered the application of data-driven models and machine learning to improve the detection, surveillance, forecasting, and control of emerging viral threats, including designing effective disease control strategies for hospitals and metropolitan areas. She is also Associate Editor of the journals Infectious Disease Modeling and Epidemics.

Bisola Olubunmi Ojikutu, MD, MPH, FIDSA

Commissioner of Public Health, City of Boston, Boston, Massachusetts

Dr. Ojikutu also serves as Executive Director of Boston Public Health Commission and as Associate Professor of Medicine at Harvard Medical School. She has dedicated her career to the prevention and treatment of HIV and other infectious diseases as a health equity researcher, clinician, public health leader, and advocate for marginalized populations. She has an impressive ability to translate research into action and integrate her academic work with community advocacy. As Boston's Commissioner of Public Health, Dr. Ojikutu led the city's successful COVID-19 response and is a member of the Mayor's Cabinet of Chief Advisors. She also mentors and teaches medical students and post-graduate trainees across the Harvard campus.

Trish M. Perl, MD, MSc

Professor, Public Health and Infectious Diseases and Geographic Medicine, The University of Texas Southwestern Medical Center, Dallas, Texas

Dr. Perl is an internationally recognized expert in healthcare-associated antimicrobial-resistant and respiratory infections whose career has significantly impacted the field of healthcare epidemiology. She has worked as a hospital and health system epidemiologist for decades and has been instrumental in implementing policies for addressing epidemiologically significant resistant organisms. Dr. Perl has written multiple book chapters and contributed to guidelines and policies relevant to healthcare-associated infections at the institutional, state, and federal levels. She also consults on guidelines development and strategies to prevent healthcare-associated infections and antimicrobial resistance.

Susan Sarah Philip, MD, MPH

Health Officer, City and County of San Francisco, San Francisco Department of Public Health, San Francisco, California

Dr. Philip also serves as Assistant Clinical Professor in the Division of Infectious Diseases, Department of Medicine, at the University of California, San Francisco. She previously served on the faculty of the California STD/HIV Prevention Training Center in Oakland. She is a member of the Infectious Diseases Society of America; past member of the Board of Directors of the National Coalition of STD Directors; and past member of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment and former Co-Chair of the committee's STD Workgroup.

Thomas E. Wittum, PhD

Professor, Department of Veterinary Preventive Medicine, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio

Dr. Wittum is an internationally recognized leader in Veterinary Public Health and expert in zoonotic infectious diseases. His research focuses on investigating the One Health emergence and dissemination of antibiotic resistant bacteria and resistance genes in humans, animals, and the environment including surface waters. He has led the development and implementation of innovative antimicrobial stewardship programs for academic and private veterinary practices in Ohio. Dr. Wittum also serves on the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) and the Advisory Council of the National Institute of Antimicrobial Resistance Research and Education (NIAMRRE).